Search 33,000+ CME courses
Back

StatPearls, LLC

  • Albendazole
  • Diethylcarbamazine
  • Doxycycline
  • Elephantiasis, Filarial
  • Pulmonary Eosinophilia

Tropical Pulmonary Eosinophilia

Tropical pulmonary eosinophilia is a hypersensitivity pulmonary syndrome caused by microfilariae trapped in the lungs, a clinical manifestation of lymphatic filariasis, primarily caused by Wuchereria bancrofti, Brugia malayi, and Brugia timori. This condition often arises in individuals residing in or traveling to filarial-endemic regions, though globalization has led to cases in developed countries. Symptoms develop gradually, including nocturnal cough, dyspnea, wheezing, fever, and systemic manifestations like weight loss. Key diagnostic markers include significant eosinophilia (>3,000/ L), elevated serum IgE and filarial antibodies, and pulmonary infiltrations on imaging. Tropical pulmonary eosinophilia treatment involves diethylcarbamazine, which targets microfilariae and adult worms and the management of airway inflammation. Alternative therapies, eg, ivermectin, albendazole, or doxycycline, may be considered where diethylcarbamazine is unavailable. Early diagnosis and treatment are crucial to prevent complications like interstitial fibrosis and respiratory impairment. This activity for healthcare professionals is designed to enhance the learner’s competence in recognizing tropical pulmonary eosinophilia, performing the recommended evaluation, and implementing an appropriate interprofessional management approach to improve patient outcomes.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 1 creditAAPA Category 1 Credit™Up to 1 creditAMA PRA Category 1 Credit™Up to 1 creditNursingUp to 1 creditPharmacyUp to 1 credit

MOC types

ABS — Accredited CMEUp to 1 pointABPATH — Lifelong LearningUp to 1 pointABTS — Accredited CMEUp to 1 pointABIM — Medical KnowledgeUp to 1 pointABS — Self-AssessmentUp to 1 pointABP — Lifelong Learning and Self-AssessmentUp to 1 pointABTS — Self-AssessmentUp to 1 point

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Cross-Specialty

Relevant across 8 specialties.

Pricing

Fee varies

This provider typically $49–98

See fees on statpearls.com

Listed by the provider

  • Article / monograph / reference
  • Credit · Up to 1 credit
  • MOC · Up to 1 point
  • Fee varies · this provider typically $49–98
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Sep 1, 2029 3 years left

Related courses

See all

Other providers’ courses on the same topic

More from StatPearls, LLC

See all

This provider’s courses closest to this one